| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/05/2009 | US20090035752 detecting whether CpG sequences in a region from base 374 to base 592 in a DR3 gene promoter region obtained from synovial cells or synovial infiltrating lymphocytes of the human subject are methylated or not |
| 02/05/2009 | US20090035382 Method and compound for the treatment of articular diseases or articular pain, or for the treatment of skin for aesthetic or other purposes, and the method of preparation of the compound |
| 02/05/2009 | US20090035376 Stem cells obtained from pulp of deciduous or permanent teeth and of dental germ, able to produce human bone tissue |
| 02/05/2009 | US20090035366 Nanoparticulate benzothiophene formulations |
| 02/05/2009 | US20090035347 Isolated stromal cells and methods of using the same |
| 02/05/2009 | US20090035306 Quinazolinone modulators of tgr5 |
| 02/05/2009 | US20090035282 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 02/05/2009 | US20090035274 Treatment and/or prevention of cancer and/or arthritis |
| 02/05/2009 | US20090035255 Conjugate for targeting of drug |
| 02/05/2009 | CA2697147A1 Cyclic inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
| 02/05/2009 | CA2695398A1 Method and compound for the treatment of articular diseases or articular pain, or for the treatment of skin for aesthetic or other purposes, and the method of preparation of the compound |
| 02/05/2009 | CA2695304A1 Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions |
| 02/05/2009 | CA2694639A1 Benzamidine derivatives, process for the preparation thereof and pharmaceutical composition for preventing or treating osteoporosis comprising the same |
| 02/05/2009 | CA2694638A1 Preventive or therapeutic agent for diseases caused by abnormal bone metbolism |
| 02/04/2009 | EP2020409A1 New piperidinyl derivatives as modulators of chemokine receptor activity |
| 02/04/2009 | EP2020408A1 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 02/04/2009 | EP2020404A1 Cyanomethyl substituted N-Acyl Tryptamines |
| 02/04/2009 | EP2020243A1 Topically applicable pharmaceutical preparation |
| 02/04/2009 | EP2020239A1 Use of IL-174 agonists for treating infectious diseases |
| 02/04/2009 | EP2019720A2 Treating muscular disorders and improving muscular function |
| 02/04/2009 | EP1542976B1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases |
| 02/04/2009 | EP1492773B1 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
| 02/04/2009 | CN101360826A Anti-alpha2 integrin antibodies and their uses |
| 02/04/2009 | CN101360499A Use of pyrazolo [1 , 5 -a] pyrimidine derivatives for inhibiting protein kinases methods for inhibiting protein kinases |
| 02/04/2009 | CN101358225A Method for preparing high sialic acid content immune globulin antibody and application |
| 02/04/2009 | CN101357204A Quality control method of traditional Chinese medicine preparation for treating pain |
| 02/04/2009 | CN101357195A Ancestral secret prescriptions for mainly treating bone knitting, injuries from falls and preparation technique thereof |
| 02/04/2009 | CN101357172A External traditional Chinese medicine for treating hyperosteogeny, urgent lumbar sprain, joint bursitis |
| 02/04/2009 | CN101357168A Medicinal wine for treating rheumatic arthritis |
| 02/04/2009 | CN101357162A Traditional Chinese medicine capable of inducing menstruation and removing bloodstasis |
| 02/04/2009 | CN101357124A Medicine for treating osteoarthritis |
| 02/04/2009 | CN100457753C N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 02/04/2009 | CN100457737C Quinolyl amide derivative and its preparation process and use |
| 02/04/2009 | CN100457178C Process for preparing bone peptide injection |
| 02/04/2009 | CN100457161C Medicament for treating protrusion of ntervertebral disc and hyperosteogeny and preparation process thereof |
| 02/04/2009 | CN100457160C Medicine for curing cervical vertebra and its preparation |
| 02/04/2009 | CN100457143C Medication for treating gout |
| 02/04/2009 | CN100457137C Polylactic acid microglobule Chinese medicine compound used for treating bone arthritis |
| 02/04/2009 | CN100457117C Application of woodruff acid with acetyl being removed in preparing medicine for treating rheumatoid arthritis |
| 02/04/2009 | CN100457088C Pharmaceutical composition comprising lipids comprising polar and nonpolar moiety parts |
| 02/03/2009 | US7485730 Pharmaceutical compounds |
| 02/03/2009 | US7485713 Polypeptides comprising growth hormone receptor extracellular domain and glycosylphosphatidylinositol |
| 02/03/2009 | US7485647 2-aminoquinoline derivatives |
| 02/03/2009 | US7485644 hydroxy{(1S)-4-pyrimidin-2-yl-1-[({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)methyl]butyl}formamide; collagenase 3 inhibitor; tissue remodelling such as embryonic development, bone formation and uterine remodelling during menstruation |
| 02/03/2009 | US7485639 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation |
| 02/03/2009 | US7485638 Pyrimidine compounds |
| 02/03/2009 | US7485628 Inhibition of STAT-1 |
| 02/03/2009 | US7485429 Genetically engineered polypeptide comprising extracellular domain of integrin subunit alpha 11; marker or target of all types of cells; drugs, vaccines |
| 02/03/2009 | US7485327 For use in pharmaceuticals, dietetics and/or cosmetics; anticancer agents; for treatment of vision defects and periodontal disease |
| 02/03/2009 | US7485310 Use of CXCL6 chemokine in the prevention or repair of cartilage defects |
| 02/03/2009 | US7485301 Complexing, therapy, prophylaxis, medical diagnosis; antibodies, antigen binding to chemokine |
| 02/03/2009 | CA2425164C (4-acylaminopiperidin-1-yl)acetamides as neurokinin antagonists |
| 02/03/2009 | CA2420040C New phenylalanine derivatives |
| 02/03/2009 | CA2377686C Mercaptoacylcysteine derivatives as therapeutic agents for osteoarthritis |
| 01/29/2009 | WO2009015000A1 Pyrazole urea derivatives used as kinase inhibitors |
| 01/29/2009 | WO2009014127A1 Composition for prevention or treatment of disease associated with the production of autoantibody |
| 01/29/2009 | WO2009013354A1 ARYLMETHYLENE SUBSTITUTED N-ACYL-β-AMINO ALCOHOLS |
| 01/29/2009 | WO2009013335A1 Organic compounds |
| 01/29/2009 | WO2009012647A1 Preparation methods of quinazoline derivatives and their pharmaceutical uses |
| 01/29/2009 | WO2008114089A3 Chymosin for the prevention and treatment of gastrointestinal disorders |
| 01/29/2009 | WO2008104278A8 Imidazo[1,2-a] pyridines and their use as pharmaceuticals |
| 01/29/2009 | WO2008059372A3 Crystal form of (3r,5r)-7-[2-(4-fluoro-phenyl)-4-isopropyl-5-(4-metyl-benzylcarbamoyl)-2h-pyrazol-3-yl]-3,5-dihydroxy-heptanoic acid sodium salt |
| 01/29/2009 | WO2007061661A4 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 01/29/2009 | US20090030051 Inhibitors of IMPDH enzyme |
| 01/29/2009 | US20090030029 Novel benzonaphthyridines |
| 01/29/2009 | US20090030027 Androgen Receptor Modulator Compounds and Methods |
| 01/29/2009 | US20090030023 Pyrimidine compounds and medicinal composition thereof |
| 01/29/2009 | US20090030012 Pyridine, Pyrimidine and Pyrazine Derivatives as Cxcr3 Receptor Modulators |
| 01/29/2009 | US20090030002 Heterocyclic compounds and their uses |
| 01/29/2009 | US20090029997 Thiazole Derivatives and Use Thereof |
| 01/29/2009 | US20090029996 Pyridazin-3(2H)-One Derivatives And Their Use As Pde4 Inhibitors |
| 01/29/2009 | US20090029995 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 01/29/2009 | US20090029994 Trisubstituted amine compound |
| 01/29/2009 | US20090029986 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |
| 01/29/2009 | US20090029955 Pyridothienopyrimidine Derivatives |
| 01/29/2009 | US20090029946 Aqueous oral solution of bisphosphonic acid |
| 01/29/2009 | US20090029929 Decoy Nucleic Acid to Synoviolin Gene Promoter |
| 01/29/2009 | US20090029915 Regulation of mineral and skeletal metabolism |
| 01/29/2009 | US20090029912 Method of enhancing proliferation and/or survival of mesenchymal precursor cells (mpc) |
| 01/29/2009 | US20090028960 Calcium phosphate-based adhesive formulation for bone filling |
| 01/29/2009 | US20090028949 Calcium phosphate-based adhesive formulation for bone filling with swelling properties |
| 01/29/2009 | US20090028924 Use of a polysaccharide which is excreted by the vibrio diabolicus species for the regeneration and protection of the periodontium |
| 01/29/2009 | US20090028876 Methods of modifying cd11c+ dendritic cell development to form osteoclasts functional in the bone environment |
| 01/29/2009 | US20090028873 Substituted cyclohexanols |
| 01/29/2009 | US20090028867 Antagonists Specific For Denatured Collagen And Methods Of Using Same |
| 01/29/2009 | US20090028859 Bispecific antibodies that bind to vegf receptors |
| 01/29/2009 | US20090028825 Compositions and Methods for Studying and Treating Inflammatory Diseases and Disorders |
| 01/29/2009 | US20090028818 Heterocyclic antiviral compounds |
| 01/29/2009 | US20090028794 Uses and compositions for treatment of psoriatic arthritis |
| 01/28/2009 | EP2018859A1 Arylmethylene substituted N-acyl-beta-amino alcohols |
| 01/28/2009 | EP2018853A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor |
| 01/28/2009 | EP2018392A1 Pharmaceutically acceptable salts and polymorphic forms |
| 01/28/2009 | EP2018211A2 Veterinary pharmaceutical compositions for the treatment of pain and inflammation |
| 01/28/2009 | EP1470826B1 Decoy-containing pharmaceutical compositions for the treatment of aneurysms |
| 01/28/2009 | EP1207755B1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation |
| 01/28/2009 | EP1177181B1 Substituted bicyclic compounds |
| 01/28/2009 | CN101353362A Extraction method of cyaniding 3-0-glucoside |
| 01/28/2009 | CN101352531A Medicinal spirit for rheumatism |
| 01/28/2009 | CN101352527A Medicament for treating rheumatic arthritis |
| 01/28/2009 | CN101352506A Medicament for treating orthopedic disorders and preparation method and use thereof |